CombinatoRx, Incorporated (CRXX) Narrows Q1 Loss Y/Y
CombinatoRx, Incorporated (Nasdaq: CRXX) reports Q1 loss of $0.05, versus ($0.24) reported for the same period a year ago. Revenue for the quarter was $41.3 million, compared to $2.6 million in Q109.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Rue21, Inc. (RUE) Tops Q1 EPS by 3c; Boosts FY12 EPS Outlook; Approves $50M Buyback
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
